Home › Neoplasie del sangue › New York
Studi clinici su Neoplasie del sangue nello stato di New York
29 studi su Neoplasie del sangue cercano partecipanti presso sedi nello stato di New York.
Città nello stato di New York
- New York City26 studi
- Buffalo7 studi
- Queens7 studi
- New Rochelle5 studi
- Greenburgh5 studi
- The Bronx4 studi
- Staten Island4 studi
- Rochester3 studi
Testo ufficiale dello studio (inglese)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0032), New York
- White Plains Hospital-Center for Cancer Care ( Site 0069), White Plains
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- NYU Langone Health, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07572006A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- Mount Sinai Medical Center, New York
- University of Rochester Medical Center, Rochester
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT04634552Genomic Profiling in Cancer Patients
- Kings County Hopsital Center, Brooklyn
- Memorial Sloan Kettering Cancer Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- e altri 7
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 24 set 2026 · NCT01775072Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 4, Buffalo
- Quetzal Site 2, The Bronx
In reclutamentoFase 3
Età da 18 a 71 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT03816345Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- David H. Koch Center for Cancer Care, New York
- Montefiore Medical Center PRIME, The Bronx
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07648264Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Hematology Oncology Associates of Central New York-Auburn, Auburn
- Roswell Park Cancer Institute, Buffalo
- Hematology Oncology Associates of CNY at Camillus, Camillus
- e altri 5
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 17 set 2026 · NCT04242095A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07195916A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
- Research Site, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT07220616Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- State University of New York at Buffalo, Buffalo
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07007312Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Roswell Park Comprehensive Cancer Center, Buffalo
- Northwell Health, LLC PRIME, Lake Success
- Memorial Sloan Kettering Cancer Center, New York
- e altri 3
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT06001788Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
- Northwell Health, Manhasset
- NYP/Weill Cornell Medical Center, New York
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT04515810A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 lug 2026 · NCT07359859Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 lug 2026 · NCT07216443A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- e altri 9
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- New York University (Data Collection Only), New York
- e altri 2
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT07006506IVIG for Infection Prevention After CAR-T-Cell Therapy
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT05952804An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
- New York Presbyterian Hospital, New York
- Mt Sinai Medical Center, New York
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 giu 2026 · NCT06401356Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 giu 2026 · NCT05663502A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
- Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- e altri 1
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 mag 2026 · NCT07052916CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Roswell Park Comprehensive Cancer Center, Buffalo
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 apr 2026 · NCT03328078A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Roswell Park Comprehensive Cancer Center, Buffalo
- New York - Presbyterian / Weill Cornell Medicine, New York
- Mount Sinai - Ruttenberg Treatment Center, New York
- e altri 2
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 mar 2026 · NCT05735184MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 gen 2026 · NCT07362225Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 apr 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età da 1 a 21 · Tutti i sessi · Aggiornato il 6 dic 2024 · NCT05476770Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT
- Memorial Sloan Kettering Cancer Center (MSKCC), New York
In reclutamentoFase 1/2
Tutte le età · Tutti i sessi · Aggiornato il 6 mar 2023 · NCT04959903The Leukemia and Lymphoma Society (LLS) National Research Registry
- Lymphoma and Leukemia Society, Rye Brook
In reclutamentoStudio osservazionale
Età 21 e oltre · Tutti i sessi · Aggiornato il 7 apr 2022 · NCT04806295Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.